Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites e

Journal Article · · Nat. Commun.

Research Organization:
Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
Sponsoring Organization:
DOE - Office Of Science; FOREIGN
OSTI ID:
1900897
Journal Information:
Nat. Commun., Journal Name: Nat. Commun. Vol. 13
Country of Publication:
United States
Language:
ENGLISH

References (57)

Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases journal January 2013
Identification of mutation resistance coldspots for targeting the SARS‐CoV2 main protease journal March 2021
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease journal October 2020
Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance journal June 2022
Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals journal December 2020
Features and development of Coot journal March 2010
A new coronavirus associated with human respiratory disease in China journal February 2020
Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography journal June 2020
Critical Assessment of Important Regions in the Subunit Association and Catalytic Action of the Severe Acute Respiratory Syndrome Coronavirus Main Protease journal April 2005
Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site journal November 2020
MolProbity : all-atom structure validation for macromolecular crystallography journal December 2009
Phaser crystallographic software journal July 2007
The SARS-CoV-2 main protease as drug target journal September 2020
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease journal September 2020
Activation and maturation of SARS-CoV main protease journal April 2011
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate journal June 2004
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations journal February 2021
Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome journal October 2021
Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease journal August 2021
SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging journal October 2020
Inference of Macromolecular Assemblies from Crystalline State journal September 2007
ACHESYM : an algorithm and server for standardized placement of macromolecular models in the unit cell journal November 2014
Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports journal November 2021
Overview of the CCP 4 suite and current developments journal March 2011
Highly accurate protein structure prediction with AlphaFold journal July 2021
PHENIX : building new software for automated crystallographic structure determination journal October 2002
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors journal March 2020
Essential covalent linkage between the chymotrypsin-like domain and the extra domain of the SARS-CoV main protease journal August 2010
Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses journal February 2022
Conservation of substrate specificities among coronavirus main proteases journal March 2002
Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease journal April 2010
Michaelis-like complex of SARS-CoV-2 main protease visualized by room-temperature X-ray crystallography journal October 2021
Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir journal April 2022
A pneumonia outbreak associated with a new coronavirus of probable bat origin journal February 2020
xia2 : an expert system for macromolecular crystallography data reduction journal December 2009
XDS journal January 2010
Polder maps: improving OMIT maps by excluding bulk solvent journal February 2017
Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main Protease journal October 2021
Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2 journal April 2022
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication journal August 2020
How good are my data and what is the resolution? journal June 2013
Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety journal January 2013
Proteases Universally Recognize Beta Strands In Their Active Sites journal March 2005
Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies journal October 2013
Unusual zwitterionic catalytic site of SARS–CoV-2 main protease revealed by neutron crystallography journal October 2020
A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease journal February 2021
N‐Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS‐CoV‐2 Main Protease journal November 2020
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease journal June 2020
Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease journal August 2021
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors journal April 2020
Processing of the SARS-CoV pp1a/ab nsp7–10 region journal March 2020
Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases journal September 2005
Viral cysteine proteinases journal December 1996
Crowdsourcing drug discovery for pandemics journal June 2020
An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19 journal December 2021
N-Terminomics TAILS Identifies Host Cell Substrates of Poliovirus and Coxsackievirus B3 3C Proteinases That Modulate Virus Infection journal April 2018
Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19 journal October 2020

Similar Records

Characterization of alternate encounter assemblies of SARS-CoV-2 main protease
Journal Article · 2024 · Journal of Biological Chemistry · OSTI ID:2441066

Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease
Journal Article · 2020 · Science Advances · OSTI ID:1815627

Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease
Journal Article · 2021 · ACS Infect. Dis. · OSTI ID:1821717

Related Subjects